How Patient Interest in Cellular Wellness Is Shaping Healthy Aging

Patients are increasingly taking the lead in conversations about longevity therapies. They're hearing about cellular energy, recovery and healthy aging through podcasts, social media and wellness influencers—often before discussing these topics with their healthcare providers. NAD+ is a good example of how a compound once largely confined to scientific discussions has become a familiar name in the wellness marketplace.

The market itself is growing rapidly. According to the Global Wellness Institute, the global wellness economy reached $6.8 trillion in 2024 and is projected to reach $9.8 trillion by 2029. Within that market, interest in cellular health is helping shape how consumers think about vitality, physical performance and aging.

NAD+, or nicotinamide adenine dinucleotide, is a naturally occurring co-enzyme involved in cellular energy production, metabolism and DNA repair. Because NAD+ levels tend to decline with age, the compound has attracted attention in longevity research and, increasingly, among consumers exploring wellness therapies. Today, NAD+ is part of the conversation at longevity clinics, integrative medicine practices, and other wellness-focused providers.

However, NAD+’s role in normal cellular function does not establish that injectable NAD+ improves energy, recovery or longevity. Clinical evidence supporting these uses remains limited.

Patients Are Bringing New Questions Into the Exam Room

Patients may already know the names of specific therapies before their healthcare provider introduces them. They've read articles, listened to interviews, or heard about someone else's experience and want to know whether a particular therapy might be right for them.

NAD+ illustrates this shift. A patient who has encountered it in a podcast or through a wellness brand may arrive with questions about how it's used, what formulations are available, and where it fits within a broader approach to healthy aging.

Those questions can open the door to more individualized discussions. Someone focused on staying active as they get older may have different priorities than a patient interested in recovery or general vitality. Understanding what prompted the inquiry helps healthcare providers address expectations and determine which options are appropriate to consider.

This presents an opportunity for practices offering longevity, integrative medicine, and wellness services. Patient inquiries can provide useful insight into emerging areas of demand, helping practices evaluate which therapies complement their existing expertise and patient populations.

Bringing Cellular Wellness Into Practice

Interest in NAD+ is one example of how consumer demand can influence the services practices consider adding. Before incorporating a new therapy, healthcare providers must evaluate the available formulations, appropriate prescribing and administration protocols, and how the treatment would fit into their existing services.

There are practical considerations as well. Sourcing, product availability, and fulfillment all affect how efficiently a practice can manage its prescription needs. For clinics offering several categories of wellness therapies, coordinating these activities across different pharmacy sources can add administrative work.

BoomRx gives healthcare providers access to a broad portfolio of compounded preparations and specialty therapies, including injectable NAD+ in multiple concentrations and vial sizes. Through one centralized platform, practices can manage ordering and fulfillment across multiple pharmacy sources.

The growing attention surrounding NAD+ offers a glimpse of how the longevity market is changing. Consumers are discovering therapies on their own and bringing new expectations into healthcare settings. Practices that understand what’s driving those conversations can make more informed decisions about which services belong in their offerings and how best to support the patients seeking them.

Compounded preparations are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. Treatment decisions remain the responsibility of licensed healthcare providers.